2021-01-

COVID-19 : Coronavirus Update click here.

Product Service Statement in regards to Delays:

We are currently experiencing very high demands within the service depot. Circumstances make it difficult to provide exact and accurate lead times.  We appreciate your understanding as processing times fluctuate. 

• Current Hillrom Order Status / Thermometry Status UPDATE

• Andreas Frank Distributor Letter
• Spirometry Filter Letter
• WADCS Spiro Filter, Customer Service Bulletin
• Canadian Hillrom Thermometry Update
• Probe Cover COVID-19 Letter for customers seeking formal stance on Hillrom Probe Cover reuse, non use, generic use and use outside temperature range.
• Internal TSB Re: SureTemp/ Braun/ CareTemp Probe Cover Requirement  
• Braun ThermoScan® PRO 4000 Ear Thermometer probe cover backorder & Braun ThermoScan® PRO 6000 Ear Thermometer probe cover compatibility with other Braun ThermoScan PRO Series ear thermometers.
• March 2020, Acute Cardiology and Vitals Newsletter - Containing COVID-19 Information.
• Effective April 1, 2020: 45 Neonatal Soft blood pressure cuffs SKUs will be on backorder for an estimated 8 weeks. US Sales & Distribution letter is located here. We can offer a product substitution during this time and the cross-referenced items are provided here. 
• Michael Finnamore has prepared this written response pertaining to Hillrom COVID-19 (Coronavirus) Personal Safety Protocols. This may be sent to the customer should they inquire. We will not be filling out any surveys provided via customer email's at this time, instead please email an attachment of this response. 
• Speaking to our Service Protocols, a written response is available here as well. 
• Should you receive inquiries regarding the 2019-nCov / Coronavirus we have the following Global Supply Chain messaging to share as well.  

Global Supply Chain

REACTIVE MESSAGE ONLY

February 3, 2020

Dear [Customer Name],

Thank you for reaching out. We are constantly monitoring our product inventory, raw materials and component needs, and are continuing to meet customer demand for our products around the world. We are carefully following Chinese government, WHO and U.S. CDC directives regarding transportation and shipping availability, and are maintaining appropriate communication with our customers.

Best regards,

[YOUR NAME]

Coronavirus

Spirometry Testing Risk

REACTIVE MESSAGE ONLY

March 3, 2020

Dear [Customer Name],

Thanks for all that you are doing to provide care for your patients and your community during the COVID 19 pandemic. 

To answer your question regarding increased risk of COVID 19 droplet infection related to PFT testing, there have not yet been clinical studies that speak to the COVID 19 transmission risk in various circumstances. So, we did a bit of research to see what the key medical associations have been saying on the topic. The American Thoracic Society provided the following guidance on their website:

We recommend that pulmonary function testing be limited to tests that are only essential for immediate treatment decisions, that the type of pulmonary function testing be limited to the most essential tests when possible, and that measures to protect both the staff and individuals being tested should be put in place. Protective measures include personal protective equipment (PPE) that limits aerosolized droplet acquisition for staff and enhanced cleaning of the testing space such as wiping down surfaces with appropriate cleaners.  Use of PPE should be considered in discussions with your infection control team.

Decisions regarding the conduct of pulmonary function tests need to balance the potential risks against the need for assessment of lung function to make treatment decisions. We realize that this is an evolving situation and that the risk/benefit ratio will also continue to change over time.

They also note that situation continues to evolve. The full statement is here.

 Please let me know if I can assist with anything else.

Thanks,

[YOUR NAME]

Should you require more detailed follow aside from these two responses, please follow up with David Maskens and Bailey Ramsden via email.